Ignoring our evolution: The 'pandemic' of over-nutrition and under-activity. Not simply a metabolic syndrome?

Anaesthesia

Volumn 69, Issue 3, 2014, Pages 203-207

  Ball, J ^a   McAnulty, G ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA; CRITICAL CARE; HUMANS; METABOLIC SYNDROME X; OBESITY; OVERNUTRITION; PANDEMICS; PERIOPERATIVE CARE; SEDENTARY LIFESTYLE;

EID: 84894339482     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12599     Document Type: Review

References (52)

1. Aydin S, Aksoy A, Kalayci M, et al. Today's and yesterday's of pathophysiology. Biochemistry of metabolic syndrome and animal models. Nutrition 2014; 30: 1-9.
2. Ashwell M, Gunn P, Gibson S,. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obesity Reviews 2012; 13: 275-86.
3. Carmienke S, Freitag MH, Pischon T, et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. European Journal of Clinical Nutrition 2013; 67: 573-85.
4. Reaven GM,. The metabolic syndrome. Requiescat in pace. Clinical Chemistry 2005; 51: 931-8.
5. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-5.
6. Silva V, Stanton KR, Grande AJ,. Harmonizing the diagnosis of metabolic syndrome-focusing on abdominal obesity. Metabolic Syndrome and Related Disorders 2013; 11: 102-8.
7. Reaven G,. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 106: 286-8.
8. Canale MP, Manca di Villahermosa S, Martino G, et al. Obesity-related metabolic syndrome. mechanisms of sympathetic overactivity. International Journal of Endocrinology 2013; 2013: 865965.
9. Alvarez-Lario B, Macarron-Vicente J,. Is there anything good in uric acid? Quarterly Journal of Medicine 2011; 104: 1015-24.
10. Pradhan G, Samson SL, Sun Y,. Ghrelin: much more than a hunger hormone. Current Opinion in Clinical Nutrition and Metabolic Care 2013; 16: 619-24.
11. Keen-Rhinehart E, Ondek K, Schneider JE,. Neuroendocrine regulation of appetitive ingestive behavior. Frontiers in Neuroscience 2013; 7: 213.
12. Cai D, Liu T,. Inflammatory cause of metabolic syndrome via brain stress and NF-kappaB. Aging 2012; 4: 98-115.
13. Klop B, Elte JW, Cabezas MC,. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013; 5: 1218-40.
14. Roberts CK, Hevener AL, Barnard RJ,. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comprehensive Physiology 2013; 3: 1-58.
15. Mark AL,. Selective leptin resistance revisited. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 2013; 305: R566-81.
16. Liesa M, Shirihai OS,. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metabolism 2013; 17: 491-506.
17. Koleva DI, Orbetzova MM, Atanassova PK,. Adipose tissue hormones and appetite and body weight regulators in insulin resistance. Folia Medica 2013; 55: 25-32.
18. Purkayastha S, Cai D,. Neuroinflammatory basis of metabolic syndrome. Molecular Metabolism 2013; 2: 356-63.
19. Bremer AA, Jialal I,. Adipose tissue dysfunction in nascent metabolic syndrome. Journal of Obesity 2013; 2013: 393192.
20. McGown C, Birerdinc A, Younossi ZM,. Adipose tissue as an endocrine organ. Clinics in Liver Disease 2014; 18: 41-58.
21. Weiss R, Bremer AA, Lustig RH,. What is metabolic syndrome, and why are children getting it? Annals of the New York Academy of Sciences 2013; 1281: 123-40.
22. Park JS, Seo JH, Youn HS,. Gut microbiota and clinical disease: obesity and nonalcoholic fatty liver disease. Pediatric Gastroenterology, Hepatology and Nutrition 2013; 16: 22-7.
23. Lubrano C, Genovesi G, Specchia P, et al. Obesity and metabolic comorbidities: environmental diseases? Oxidative Medicine and Cellular Longevity 2013; 2013: 640673.
24. Benyshek DC,. The "early life" origins of obesity-related health disorders: new discoveries regarding the intergenerational transmission of developmentally programmed traits in the global cardiometabolic health crisis. American Journal of Physical Anthropology 2013; 152 (Suppl 57): 79-93.
25. Schwenk RW, Vogel H, Schurmann A,. Genetic and epigenetic control of metabolic health. Molecular Metabolism 2013; 2: 337-47.
26. Abel ED, O'Shea KM, Ramasamy R,. Insulin resistance: metabolic mechanisms and consequences in the heart. Arteriosclerosis, Thrombosis, and Vascular Biology 2012; 32: 2068-76.
27. Huffman C, Wagman G, Fudim M, Zolty R, Vittorio T,. Reversible cardiomyopathies-a review. Transplantation Proceedings 2010; 42: 3673-8.
28. Rask-Madsen C, Kahn CR,. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2012; 32: 2052-9.
29. Szasz T, Bomfim GF, Webb RC,. The influence of perivascular adipose tissue on vascular homeostasis. Vascular Health and Risk Management 2013; 9: 105-16.
30. Iyer SR,. Sleep and type 2 diabetes mellitus-clinical implications. Journal of the Association of Physicians of India 2012; 60: 42-7.
31. Mandal S, Hart N,. Respiratory complications of obesity. Clinical Medicine 2012; 12: 75-8.
32. Barranco P, Delgado J, Gallego LT, et al. Asthma, obesity and diet. Nutricion Hospitalaria 2012; 27: 138-45.
33. Alicic RZ, Patakoti R, Tuttle KR,. Direct and indirect effects of obesity on the kidney. Advances in Chronic Kidney Disease 2013; 20: 121-7.
34. Zambo V, Simon-Szabo L, Szelenyi P, Kereszturi E, Banhegyi G, Csala M,. Lipotoxicity in the liver. World Journal of Hepatology 2013; 5: 550-7.
35. Kim B, Feldman EL,. Insulin resistance in the nervous system. Trends in Endocrinology and Metabolism 2012; 23: 133-41.
36. Guillet C, Masgrau A, Walrand S, Boirie Y,. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obesity Reviews 2012; 13 (Suppl 2): 51-7.
37. Sellam J, Berenbaum F,. Is osteoarthritis a metabolic disease? Joint Bone Spine 2013; 80: 568-73.
38. Rho YH, Zhu Y, Choi HK,. The epidemiology of uric acid and fructose. Seminars in Nephrology 2011; 31: 410-9.
39. de Heredia FP, Gomez-Martinez S, Marcos A,. Obesity, inflammation and the immune system. Proceedings of the Nutrition Society 2012; 71: 332-8.
40. Blokhin IO, Lentz SR,. Mechanisms of thrombosis in obesity. Current Opinion in Hematology 2013; 20: 437-44.
41. Catalan V, Gomez-Ambrosi J, Rodriguez A, Fruhbeck G,. Adipose tissue immunity and cancer. Frontiers in Physiology 2013; 4: 275.
42. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R,. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506-14.
43. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-31.
44. Knop FK, Taylor R,. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care 2013; 36 (Suppl 2): S287-91.
45. Cereda M, Neligan PJ, Reed AJ,. Noninvasive respiratory support in the perioperative period. Current Opinion in Anesthesiology 2013; 26: 134-40.
46. Brackbill ML, Sytsma CS, Sykes K,. Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient's sex. American Journal of Critical Care 2009; 18: 468-73.
47. Gonzalez Della Valle A, Chiu YL, Ma Y, Mazumdar M, Memtsoudis SG,. The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. Journal of Arthroplasty 2012; 27: 1743-9 e1.
48. Memtsoudis SG, Kirksey M, Ma Y, et al. Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine 2012; 37: 989-95.
49. Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG,. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization. Journal of Vascular Surgery 2009; 49: 1172-80 e1.
50. Turrentine FE, Hanks JB, Schirmer BD, Stukenborg GJ,. The relationship between body mass index and 30-day mortality risk, by principal surgical procedure. Archives of Surgery 2012; 147: 236-42.
51. Dickerson RN,. The obesity paradox in the ICU: real or not? Critical Care 2013; 17: 154.
52. Rattan R, Nasraway SA Jr,. Separating wheat from chaff: examining the obesity paradox in the critically ill. Critical Care 2013; 17: 168.